Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 31 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
Follow-Up Questions
¿Cuál es el ratio P/E de Park Ha Biological Technology Co Ltd (PHH)?
El ratio P/E de Park Ha Biological Technology Co Ltd es 180.5366
¿Quién es el CEO de Park Ha Biological Technology Co Ltd?
Ms. Xiaoqiu Zhang es el Chairman of the Board de Park Ha Biological Technology Co Ltd, se unió a la empresa desde 2022.
¿Qué tal es el rendimiento del precio de la acción PHH?
El precio actual de PHH es de $0.3369, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Park Ha Biological Technology Co Ltd?
Park Ha Biological Technology Co Ltd pertenece a la industria Retail y el sector es Consumer Discretionary
¿Cuál es la capitalización bursátil de Park Ha Biological Technology Co Ltd?
La capitalización bursátil actual de Park Ha Biological Technology Co Ltd es $11.4M
